Breaking News Instant updates and real-time market news.

FBHS

Fortune Brands

$58.54

0.03 (0.05%)

 16:10
10/23/19
 10/23
16:10
 10/23/19
16:10

Fortune Brands narrows FY19 EPS view $3.53-$3.63, consensus $3.60

The company's 2019 annual outlook is based on a U.S. home products market growth assumption of 2% to 2.5% and an assumption of 2% to 2.5% growth for our total global market. The company's FY19 sales growth expectation is tightened to the range of 5% to 6%, reflecting the slower ramp up of building product demand in the U.S., and the weaker Canadian housing market. As a result, the Company tightens its full-year 2019 EPS outlook before charges/gains to $3.53 to $3.63. The company expects to generate free cash flow of approximately $480M to $500M for FY19, which includes accelerated investments in capacity and inventory to support new composite decking customers.

  • 23

    Oct

FBHS Fortune Brands
$58.54

0.03 (0.05%)

05/06/19
BOFA
05/06/19
UPGRADE
BOFA
Buy
Fortune Brands upgraded to Buy from Neutral at BofA/Merrill
07/02/19
LOOP
07/02/19
DOWNGRADE
LOOP
Hold
Fortune Brands downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Laura Champine downgraded Fortune Brands Home & Security to Sell from Hold.
07/02/19
LOOP
07/02/19
DOWNGRADE
Target $50
LOOP
Sell
Fortune Brands downgraded to Sell at Loop Capital, $50 price target maintained
Loop Capital analyst Laura Champine downgraded Fortune Brands Home & Security to Sell from Hold with a $50 price target following the company's 20% bounce in the second quarter on top of a 25% move in the first quarter. In a research note to investors, Champine says that while lower mortgage rates may drive improving remodeling trends in the second half of the year, she feels this is more than sufficiently priced into the stock already. The analyst also says she is concerned that slower home price improvements may eventually create a headwind to remodeling activity that is not consistent with management's guidance.
09/26/19
JPMS
09/26/19
UPGRADE
Target $172
JPMS
Overweight
JPMorgan upgrades Whirlpool to Overweight, boosts price target to $172
JPMorgan analyst Michael Rehaut upgraded Whirlpool (WHR) to Overweight from Neutral and raised his price target for the shares to $172 from $155. The analyst expects U.S. industry shipments to be more stable year-over-year through the end of 2019 and show "modest" growth in 2020. Further, he thinks point to steel prices will remain "at bay" and that Whirlpool's European operations will "finally" turn a small profit in the second half of 2019. In addition, Rehaut views the stock's valuation as inexpensive. The analyst this morning also downgraded Beacon Roofing Supply (BECN) to Underweight from Neutral. His top picks in the Building Products sector remain Stanley Black & Decker (SWK) and Fortune Brands (FBHS).

TODAY'S FREE FLY STORIES

MMNFF

MedMen

$0.00

(0.00%)

 14:25
12/12/19
12/12
14:25
12/12/19
14:25
Conference/Events
MedMen management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FB

Facebook

$200.86

-1.37 (-0.68%)

 14:22
12/12/19
12/12
14:22
12/12/19
14:22
Periodicals
FTC considers injunction to block Facebook policies on app integration, WSJ says »

The Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
AMRX

Amneal Pharmaceuticals

$5.00

1.515 (43.47%)

 14:17
12/12/19
12/12
14:17
12/12/19
14:17
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
LUV

Southwest

$54.65

0.67 (1.24%)

, BA

Boeing

$346.36

-3.64 (-1.04%)

 14:17
12/12/19
12/12
14:17
12/12/19
14:17
Periodicals
Southwest weighs another delay in 737 MAX's return to schedule, Bloomberg says »

Southwest Airlines (LUV)…

LUV

Southwest

$54.65

0.67 (1.24%)

 BA

Boeing

$346.36

-3.64 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

 14:17
12/12/19
12/12
14:17
12/12/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
FB

Facebook

$200.80

-1.43 (-0.71%)

 14:16
12/12/19
12/12
14:16
12/12/19
14:16
Periodicals
FTC considering injunction against Facebook, WSJ says »

The potential FTC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
$NYE

NYSE Market Internals

$0.00

(0.00%)

 14:16
12/12/19
12/12
14:16
12/12/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
ITCI

Intra-Cellular

$12.67

0.53 (4.37%)

 14:15
12/12/19
12/12
14:15
12/12/19
14:15
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

TISI

Team

$15.98

-0.03 (-0.19%)

 14:14
12/12/19
12/12
14:14
12/12/19
14:14
Initiation
Team initiated  »

Team initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

, MO

Altria Group

$50.38

0.075 (0.15%)

… 14:11
12/12/19
12/12
14:11
12/12/19
14:11
Periodicals
CDC says many brands likely responsible for vaping-related injuries, Verge says »

The Centers for Disease…

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

 MO

Altria Group

$50.38

0.075 (0.15%)

 PM

Philip Morris

$84.20

-0.8 (-0.94%)

 IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan
NXGN

NextGen Healthcare

$17.10

-1.01 (-5.58%)

 14:11
12/12/19
12/12
14:11
12/12/19
14:11
Hot Stocks
NextGen Healthcare down 6% after guiding 'relatively flat' earnings until FY23 »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMRX

Amneal Pharmaceuticals

$5.04

1.555 (44.62%)

 14:09
12/12/19
12/12
14:09
12/12/19
14:09
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
NXGN

NextGen Healthcare

$17.39

-0.72 (-3.98%)

 14:08
12/12/19
12/12
14:08
12/12/19
14:08
Earnings
NextGen Healthcare lowers FY20 EPS outlook, raises low-end of FY20 revenue view »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

APO

Apollo Global

$44.31

-0.66 (-1.47%)

, GE

General Electric

$11.36

0.375 (3.42%)

… 14:06
12/12/19
12/12
14:06
12/12/19
14:06
Hot Stocks
Apollo, Athene close the acquisition of GE Capital's PK AirFinance debt business »

Apollo Global Management…

APO

Apollo Global

$44.31

-0.66 (-1.47%)

 GE

General Electric

$11.36

0.375 (3.42%)

 ATH

Athene Holding

$45.09

1.12 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 26

    Feb

CIEN

Ciena

$41.74

6.29 (17.74%)

 14:06
12/12/19
12/12
14:06
12/12/19
14:06
Recommendations
Ciena analyst commentary  »

Ciena's long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec
BMRN

BioMarin

$80.03

1.25 (1.59%)

 14:05
12/12/19
12/12
14:05
12/12/19
14:05
Options
BioMarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

, AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

… 13:59
12/12/19
12/12
13:59
12/12/19
13:59
Recommendations
TherapeuticsMD, Amneal Pharmaceuticals, Merck analyst commentary  »

Stifel says…

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

 AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

 MRK

Merck

$89.27

0.31 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

HURN

Huron

$69.15

0.23 (0.33%)

 13:57
12/12/19
12/12
13:57
12/12/19
13:57
Conference/Events
Huron management to meet with Benchmark »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

13:55
12/12/19
12/12
13:55
12/12/19
13:55
Conference/Events
The FDIC to hold a Board Meeting »

Board of Directors…
MLNT

Melinta Therapeutics

$1.71

0.15 (9.62%)

 13:48
12/12/19
12/12
13:48
12/12/19
13:48
Hot Stocks
FDA approves Melinta Therapeutics sNDA for Orbactiv for injection »

A letter posted by the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
TTWO

Take-Two

$122.30

-0.08 (-0.07%)

 13:45
12/12/19
12/12
13:45
12/12/19
13:45
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

KW

Kennedy Wilson

$22.26

-0.25 (-1.11%)

 13:44
12/12/19
12/12
13:44
12/12/19
13:44
Hot Stocks
Kennedy Wilson raises quarterly dividend 5% to 22c per share »

Kennedy Wilson announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

, SPX

S&P 500

$0.00

(0.00%)

 13:38
12/12/19
12/12
13:38
12/12/19
13:38
Periodicals
WH Press Secretary says President to hold trade meeting at 2:30, CNBC reports »

CNBC political reporter…

SPY

SPDR S&P 500 ETF Trust

$316.35

1.94 (0.62%)

 SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
GILD

Gilead

$67.62

0.48 (0.71%)

 13:36
12/12/19
12/12
13:36
12/12/19
13:36
Periodicals
PrEP4All says USPTO adviser showed 'bias' in favor of Gilead, STAT reports »

An AIDS activist group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial
BCS

Barclays

$8.98

0.01 (0.11%)

 13:35
12/12/19
12/12
13:35
12/12/19
13:35
Options
Barclays put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.